top of page

Participation at scientific conferences

 

1. Keynote Speaker in the 4th International Conference for Young Scientists in Basic and Applied Science "New Trends in Basic Science (Present and Future)", Faculty of Science, Assiut University, April 29-30, 2014.

 

2. Keynote Speaker in the 5th International Scientific Conference of Faculty of Pharmacy " Pharmacy at the Cutting-edge: Facing Future Challenges", Cairo University, April 23-24, 2014.

 

3. Keynote Speaker in "Nanotechnology & Nursing”, Community Health Nursing Department, Faculty of Nursing, Assiut University, April 1, 2014.

 

4. Keynote Speaker in Assiut University 9th International Pharmaceutical Science Conference ", Revolution in drug discovery", Assiut University, March 12-13, 2014.

 

5. Mahmoud Elsabahy. Development of Multifunctional Nanotheranostics for Therapeutic and Imaging Applications. 63rdLindau Nobel Laureate Meeting, Lindau, Germany, June 30-July 5, 2013. Selected among 13 young researchers worldwide as a speaker in this meeting.

 

6. Shiyi Zhang, Fuwu Zhang, Jiong Zou, Mahmoud Elsabahy, Karen L Wooley.Versatile construction of polyphosphoester-based nanostructures for different biological applications. 245th ACS National Meeting & Exposition, New Orleans, Louisiana, United States, April 7-11, 2013.

 

7. Ritu Shrestha, Mahmoud Elsabahy, Hannah Luehmann, Sandani Samarajeewa, Stephanie Florez-Malaver, Nam S. Lee, Michael J. Welch, Yongjian Liu, Karen L. Wooley. Hierarchically Assembled Theranostic Nanostructures for siRNA Delivery and Imaging Applications. Program of Excellence in Nanotechnology, Integrated Nanosystems for Diagnosis and Therapy,Annual Inter-PEN Meeting, Massachusetts General Hospital, Boston, MA(October 2012).

 

8. Shiyi Zhang, Jiong Zou,Fuwu Zhang, Mahmoud Elsabahy,Karen L. Wooley. Oral presentation at the 244thACS National Meeting, Philadelphia, PA, United States, August 2012, "Rapid and versatile construction of diverse and functional nanostructures derived from a polyphosphoester-based biomimetic block copolymer system"

 

9. Sandani Samarajeewa, Mahmoud Elsabahy, Ritu Shrestha, Ryan Zentay, Karen L. Wooley. Development of degradable cationic shell crosslinked nanoparticles toward efficient transfection of nucleic acids. From Abstracts of Papers, 244th ACS National Meeting & Exposition, Philadelphia, PA, United States, August 19-23, 2012 (2012), PMSE-84.

 

10. Mahmoud Elsabahy. Nanotechnology in Medicine Workshop, Integrated Nanosystems for Diagnosis and Therapy, A Program of Excellence in Nanotechnology (PEN), Supported by the National Heart Lung and Blood Institute (NHLBI), St. Louis, MO (July 2012)

 

11. Mahmoud Elsabahy, Program of Excellence in Nanotechnology, Integrated Nanosystems for Diagnosis and Therapy,3rd Annual Intra-PEN Meeting, Washington University School of Medicine, St. Louis, MO (July 2012).

 

12. Mahmoud Elsabahy. Texas A&M Program of Excellence in Nanotechnology group. 1st Inter-PEN Contract Meeting, St. Louis, MO (November 2011).

 

13. Arnaud E. Felber, Bastien Castagner, Mahmoud Elsabahy, Glen F. Deleavey, Masad J. Damhaand Jean-Christophe Leroux. Polymeric micelles with detachable shell prepared by ATRP for siRNA delivery, 242nd National Meeting of the American-Chemical-Society (ACS), Denver, CO.(August-September 2011).

 

14. Mahmoud Elsabahy, MacDonald Donkuru, Ildiko Badea, Ronald Verrall and Marianna Foldvari. pH-Sensitive Gemini Surfactant-Lipid Composite Nanoparticles as Novel Constructs for Topical Gene Therapy.The 38th annual meeting and exposition of the controlled release society, Gaylord National Resort and Convention Center, National Harbor, Maryland (July 2011).

 

15. Mahmoud Elsabahy, Ildiko Badea, Ronald Verrall and Marianna Foldvari. Cutaneous gene delivery using pyrene-substituted gemini-lipid nanoparticles. The 14th annual meeting of the American society of gene & cell therapy, ASGCT translational science training course, Seattle, Washington (May 2011).

 

16. Marianna Foldvari (CRC),Mahmoud Elsabahy and Torin Huzil. Non-invasive nanomedicines: Gene and protein delivery systems. Canada Research Chairs (CRC), Thinking Ahead for a Strong Future, Toronto, Ontario, Canada(November 2010).

 

17. Evi Saliaj,Mahmoud Elsabahy,Marina Ivanova and MariannaFoldvari.Confocal microscopic study of diameter dependent delivery ofsiRNA into keratinocytes by multiwall carbon nanotubes. NT10 11th International Conference on the Science and Application of Nanotubes, Montreal, Quebec, Canada (June 2010).

 

18. Mahmoud Elsabahy, Mingzhen Zhang, Shao-Ming Gan, Karen C. Waldron and Jean-Christophe Leroux. PEGylated oligonucleotide duplexes and their self-assemblies with polyamidoamine dendrimers. The 35th annual meeting and exposition of the controlled release society, New York, NY (July 2008).

 

19. Núria Bayó-Puxan, Francis Robert, Jeremy G. Lackey, Nada Wazen, Mahmoud Elsabahy, Jerry Pelletier, Masad J. Damha and Jean-Christophe Leroux. Improving the intracellular delivery and efficacy of FANA oligonucleotides through lipophilic conjugation. The 35th Northeastern Regional Meeting of the American Chemical Society, Burlington, VT (June 2008).

 

20. M. J. Damha, J. K. Watts, N. Bayó, J. Lackey, G. Deleavey, N. Wazen, Mahmoud Elsabahy and Jean-Christophe Leroux. RNA Targeting with 2’-Fluoro-2’-deoxyarabinonucleic acids (2'F-ANA). American Chemical Society Conference, New Orleans, LA (April 2008).

 

21. Mahmoud Elsabahy, Ga-er Yu and Jean-Christophe Leroux. Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. The 10th Canadian Society for Pharmaceutical Sciences, Montreal, Quebec, Canada (June 2007).

 

22. Mahmoud Elsabahy, Ga-er Yu and Jean-Christophe Leroux. Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. The Annual General Assembly (McGill University), Montreal, Quebec Canada (March 2007).

 

23. Noha Elnagar, Michihiro Satoh, Miki Hosaka, Kei Asayama and Yutaka Imai. The velocity of home blood pressure reduction in response to low-dose eplerenone combined with other antihypertensive drugs determined by exponential decay function analysis. The 15th Japanese Annual Conference on Chrono cardiology and Hypertension, Tokyo, Japan (August 2013).

 

bottom of page